Loomis, Sayles & Company’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-467,655
Closed -$20.2M 835
2021
Q3
$20.2M Sell
467,655
-47,796
-9% -$2.94M 0.02% 301
2021
Q2
$33.6M Buy
+515,451
New +$32.6M 0.04% 232
2018
Q4
Sell
-103,951
Closed -$25.4M 881
2018
Q3
$25.4M Sell
103,951
-30,958
-23% -$7.16M 0.05% 180
2018
Q2
$25.1M Sell
134,909
-43,038
-24% -$7.16M 0.05% 193
2018
Q1
$21.9M Sell
177,947
-5,993
-3% -$732K 0.05% 220
2017
Q4
$21.9M Sell
183,940
-42,713
-19% -$4.7M 0.05% 245
2017
Q3
$21.6M Sell
226,653
-5,459
-2% -$526K 0.05% 260
2017
Q2
$22.1M Sell
232,112
-70,606
-23% -$6.03M 0.05% 230
2017
Q1
$23.5M Sell
302,718
-81,186
-21% -$5.63M 0.06% 220
2016
Q4
$25.8M Sell
383,904
-19,729
-5% -$1.22M 0.06% 200
2016
Q3
$24.2M Sell
403,633
-18,359
-4% -$1.02M 0.06% 205
2016
Q2
$21.1M Sell
421,992
-12,830
-3% -$612K 0.06% 252
2016
Q1
$19.6M Sell
434,822
-69,342
-14% -$2.47M 0.06% 271
2015
Q4
$20.2M Sell
504,164
-2,282
-0.5% -$96.5K 0.06% 279
2015
Q3
$24.6M Buy
506,446
+2,267
+0.4% +$108K 0.07% 225
2015
Q2
$22.5M Buy
504,179
+188,547
+60% +$7.23M 0.06% 289
2015
Q1
$10.1M Buy
+315,632
New +$10.2M 0.03% 487

Other funds holding INGN

Loomis, Sayles & Company's INGN Position: Q4 2021 in Review

Loomis, Sayles & Company sold out of Inogen (INGN) in Q4 2021, closing a stake of 467,655 shares — an estimated $20.2M sold.

Loomis, Sayles & Company first reported a position in INGN in Q1 2015 and held it in 17 quarters. The position peaked at $33.6M in Q2 2021. 168 funds tracked by Wall St. Rank hold INGN as of Q4 2021.

  • Loomis, Sayles & Company reported no remaining Inogen position as of Q4 2021 after selling out during the quarter.
  • Loomis, Sayles & Company sold 467,655 Inogen shares in Q4 2021, an estimated $20.2M.
  • Loomis, Sayles & Company first reported a position in Inogen in Q1 2015 and held it in 17 quarters.
  • Loomis, Sayles & Company's Inogen position peaked at $33.6M in Q2 2021.
  • 168 funds tracked by Wall St. Rank held Inogen as of Q4 2021.

Based on Loomis, Sayles & Company's 13F filing for Q4 2021, filed 14 Feb 2022.